Charlotte's Web Holdings Business Summary

Charlotte’s Web Holdings, Inc. (CWBHF) operates a vertically integrated business model focused on the production and distribution of premium hemp-derived cannabidiol (CBD) wellness products. The company generates revenue primarily through two segments: Direct-to-Consumer (DTC), driven by its high-traffic e-commerce platform, and Business-to-Business (B2B), which utilizes a network of retail partners and a margin-accretive distributor model. Its diverse product portfolio includes tinctures, gummies, capsules, topicals, and pet products, recently expanded by the Brightside™ line of hemp-derived THC products and clinical-grade CBN sleep solutions. Direct competitors include CV Sciences, cbdMD, Medterra, and Tilray; Charlotte’s Web maintains its position as the premium market leader in the hemp CBD category, distinguishing itself through rigorous clinical validation and a strategic shift toward pharmaceutical-grade botanical wellness. The company was founded in 2013 by the seven Stanley brothers, with co-founder Jared Stanley continuing to serve as a Director and key executive. The leadership team is led by CEO William (Bill) Morachnick, a global executive who previously served as President of Santa Fe Reynolds Tobacco International, where he scaled the business to a $5 billion acquisition. Supporting him are CFO Erika Lind, who brings over two decades of financial leadership from brands like Celestial Seasonings, and Chief Scientific Officer Dr. Marcel Bonn-Miller, a renowned cannabinoid research expert overseeing the company’s R&D and technical initiatives. Notable institutional backing includes a significant strategic investment from British American Tobacco (BAT), represented on the board by M. Borgia Walker, alongside Board Chairperson Angela McElwee, the former CEO of Gaia Herbs.